Cited 5 time in
Double-blind randomized controlled trial on efficacy of cupulolith repositioning maneuver for treatment of apogeotropic horizontal canal benign paroxysmal positional vertigo
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kong, Tae Hoon | - |
| dc.contributor.author | Song, Mee Hyun | - |
| dc.contributor.author | Kang, Jin Wook | - |
| dc.contributor.author | Shim, Dae Bo | - |
| dc.date.accessioned | 2022-07-08T00:24:35Z | - |
| dc.date.available | 2022-07-08T00:24:35Z | - |
| dc.date.issued | 2020-06 | - |
| dc.identifier.issn | 0001-6489 | - |
| dc.identifier.issn | 1651-2251 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/145566 | - |
| dc.description.abstract | Backgrounds: Although various therapeutic maneuvers have been proposed, it is still unclear which maneuver is better to treat apogeotropic horizontal canal benign paroxysmal positional vertigo (HC-BPPV). Objectives: This study aimed to assess the therapeutic efficacy of the cupulolith repositioning maneuver (CuRM) in apogeotropic HC-BPPV in comparison with the therapeutic head-shaking maneuver and modified Lempert maneuver. Materials and Method: This is double-blind randomized prospective study. Forty-nine consecutive patients diagnosed with apogeotropic HC-BPPV were allocated randomly to CuRM (n = 18), therapeutic head-shaking (n = 16), or modified Lempert maneuver (n = 15). The presence of nystagmus and vertigo on positional testing were evaluated at 30 min, on 1 day, and 1 week after treatment. Results: There were no significant differences in any clinical characteristics between the three groups at randomization. After a single trial of therapeutic maneuvers on the initial visit day, the CuRM (38.9%) and therapeutic head shaking maneuver (12.5%) did not show differences compared to modified Lempert maneuver (33.3%). The therapeutic effects on the 2nd day and at 1 week after treatment also did not differ between the three groups. Conclusions: Although the CuRM is theoretically considered to be a better therapeutic method, the therapeutic efficacy of CuRM was not statistically different compared to the other two maneuvers. | - |
| dc.format.extent | 6 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Taylor & Francis | - |
| dc.title | Double-blind randomized controlled trial on efficacy of cupulolith repositioning maneuver for treatment of apogeotropic horizontal canal benign paroxysmal positional vertigo | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1080/00016489.2020.1736339 | - |
| dc.identifier.scopusid | 2-s2.0-85081884493 | - |
| dc.identifier.wosid | 000523963400001 | - |
| dc.identifier.bibliographicCitation | Acta Oto-Laryngologica, v.140, no.6, pp 473 - 478 | - |
| dc.citation.title | Acta Oto-Laryngologica | - |
| dc.citation.volume | 140 | - |
| dc.citation.number | 6 | - |
| dc.citation.startPage | 473 | - |
| dc.citation.endPage | 478 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Otorhinolaryngology | - |
| dc.relation.journalWebOfScienceCategory | Otorhinolaryngology | - |
| dc.subject.keywordPlus | VARIANT | - |
| dc.subject.keywordAuthor | Benign paroxysmal positional vertigo | - |
| dc.subject.keywordAuthor | Semicircular canals | - |
| dc.subject.keywordAuthor | Randomized controlled trial | - |
| dc.subject.keywordAuthor | Vertigo | - |
| dc.subject.keywordAuthor | Dizziness | - |
| dc.identifier.url | https://www.tandfonline.com/doi/full/10.1080/00016489.2020.1736339 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
